Tahoe Therapeutics
South San Francisco · Founded 2022
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- tahoebio.ai
About
Tahoe Therapeutics (formerly Vevo Therapeutics) is an AI-enabled biotechnology company building virtual models of the human cell to design better drugs. The company generates hundreds of millions of single-cell data points through its proprietary platform, mapping how drug molecules interact with patient biology. Its gigascale, perturbative single-cell maps and the AI models trained on them have enabled novel therapeutic discoveries in cancer. Founded in 2022, Tahoe is based in South San Francisco, California, and has raised $30M to build the world's largest dataset for training AI models of human cells. The company collaborates with NVIDIA, the Arc Institute, and Biohub, and has open-sourced its Tahoe-100M dataset.
Summary
Tahoe Therapeutics is a Life Sciences company based in South San Francisco, founded in 2022.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...